A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2006
11/02/2006	EP1717235A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006	EP1717234A1 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006	EP1717233A1 Histamine H3-receptor ligands and their therapeutic application
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716867A1 Preventives for migraine
11/02/2006	EP1716864A1 Neural regeneration using home bone morphogenetic proteins
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716235A2 Inhibitors of tgf-r signaling for treatment of cns disorders
11/02/2006	EP1716148A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
11/02/2006	EP1716147A1 Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
11/02/2006	EP1716146A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
11/02/2006	EP1716145A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
11/02/2006	EP1716143A1 Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006	EP1716130A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006	EP1716126A1 Morpholine derivatives as norepinephrine reuptake inhibitors
11/02/2006	EP1716125A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
11/02/2006	EP1715921A2 Tetrahydroindolone derivatives for treatment of neurological conditions
11/02/2006	EP1715886A2 Hydrocephalus treatment
11/02/2006	EP1715868A1 Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1715857A1 Amidine derivatives for treating amyloidosis
11/02/2006	EP1715843A1 Combination of a nmda receptor antagonist and a mao-inhibitor or a gadph-inhibitor for the treatment of central nervous system-related conditions
11/02/2006	EP1585744B1 Process for making ondansetron and intermediates thereof
11/02/2006	EP1556037B1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity
11/02/2006	EP1515967B1 2-heteroaryl carboxamides
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1343773B1 Thiazole derivatives for traeing ppar related disorders
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1315700B1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
11/02/2006	EP1250313B1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl\|cyclohexanecarboxylate
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1127045B1 Triphenylbutene derivatives for the treatment of neurological disorders
11/02/2006	EP1102589B1 Topical compositions comprising an opioid analgesic and an nmda antagonist
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	EP0769961B1 Use of bacterial enzymes e.g. heparinases, chondroitinases for modulating wound healing processes
11/02/2006	DE102005020976A1 Use of thiamine to treat and/or prevent diseases associated with DNA lesion in single and/or double strands e.g. cancer, neurodegenerative disease, inflammatory disease and arteriosclerosis
11/02/2006	DE102005020798A1 Pharmaceutical for treatment of central nervous system diseases, comprises toll-like receptor ligand and/or Nod2 ligand
11/02/2006	CA2607475A1 Method for treating dementia or alzheimer's disease with a cd20 antibody
11/02/2006	CA2606087A1 Novel oxadiazole derivatives and their medical use
11/02/2006	CA2606086A1 Trpv1 agonist compounds and methods for making and using the same
11/02/2006	CA2606011A1 Pro-drugs of n-thiazol-2yl-benzamide derivatives
11/02/2006	CA2605603A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605587A1 Chromane and chromene derivatives and uses thereof
11/02/2006	CA2605580A1 Benzodioxane and benzodioxolane derivatives and uses thereof
11/02/2006	CA2605554A1 Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
11/02/2006	CA2605447A1 Therapeutic combinations for the treatment or prevention of psychotic disorders
11/02/2006	CA2605435A1 Dihydrobenzofuran derivatives and uses thereof
11/02/2006	CA2605381A1 Crystal polymorphism of 4'-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3',5'-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	CA2605267A1 Acetylene derivatives
11/02/2006	CA2605265A1 Acetylene derivatives
11/02/2006	CA2605117A1 Treatment of pain
11/02/2006	CA2605069A1 Treatment of drug abuse
11/02/2006	CA2604916A1 Dihydrobenzofuran derivatives and uses thereof
11/02/2006	CA2604915A1 New therapeutic combinations for the treatment or prevention of depression
11/02/2006	CA2604759A1 Dihydrobenzofuran derivatives and uses thereof
11/02/2006	CA2603900A1 Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
11/02/2006	CA2505808A1 Niacin used as oral supplementation for the treatment of psychosis and/or schizophrenia in humans
11/01/2006	CN1856499A New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
11/01/2006	CN1856497A Ligands
11/01/2006	CN1856495A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856494A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856493A Aminopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856492A Imidazo(4,5-B)pyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856491A Imidazopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856485A Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
11/01/2006	CN1856471A A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline
11/01/2006	CN1856308A Excitatory amino acid receptor antagonists
11/01/2006	CN1856301A Curable beta-amino acid
11/01/2006	CN1854151A Dopamine transfer protein peptide inhibitor and its use
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006	CN1853728A Method prescription and use for improving medicine or nutrient oral absorption
11/01/2006	CN1853722A Methods for preventing antipsychotic-induced weight gain
11/01/2006	CN1853715A Anshen Bunao soft capasule and preparation thereof
11/01/2006	CN1853714A Wuren alcohol soft capasule and preparation thereof
11/01/2006	CN1853713A Anshen Bunao drip ball and preparation thereof
11/01/2006	CN1853712A Externally-applied milk membrane for treating facial neuroparalysis and making method thereof
11/01/2006	CN1853698A Compound preparation for treating facial paralysis and its making method
11/01/2006	CN1853682A Plant based dietary supplement for improving the duration and quality of sleep
11/01/2006	CN1853681A Medicine for treating nervous prostration and improving sleep
11/01/2006	CN1853667A Use of Dafabiao extract in pharmacy
11/01/2006	CN1853663A Analgesic
11/01/2006	CN1853646A Compound three-vitamines B injection and preparation thereof
11/01/2006	CN1853638A Methods for treating delirium using glucocorticoid receptor-specific antagonists
11/01/2006	CN1853637A Use of pentacyclic triterpene compound as glycogen phosphorylase inhibitor
11/01/2006	CN1853633A USe of beta-FNA in dementia praecox treatment
11/01/2006	CN1853631A Fast disintegrant containing paroxetine
11/01/2006	CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/01/2006	CN1853619A Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
11/01/2006	CN1282648C Method for preparation of pure citalopram
11/01/2006	CN1282644C Indane or indoline derivative
11/01/2006	CN1282480C Head ache capsule preparation
11/01/2006	CN1282463C Chinese medicinal composition possessing liver calming, promoting blood flow and tranquilization and its preparation method and application
11/01/2006	CN1282456C Paroxetine control-released composite

1 ... 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 ... 1833